Announcement PDF RNS Number : 1217C Genedrive PLC 05 February 2020 Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them genedrive plc (LSE: GDR) ("genedrive" or the "Company"), the near patient molecular diagnostics company, announces that Lisa Miele, a Person Closely Associated with Gino Miele R&D Director and a PDMR, acquired 8,636 ordinary shares of 1.5p each ("Ordinary Shares") in the Company at a price of 8.875p per today. Following these purchases, Gino Miele's total beneficial interest is 66,979 Ordinary Shares, 0.2% of the issued share capital of the Company. The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014. 1. a. 2. a. a. 3. a. b. 4. a. b. c. d. Details of the person discharging managerial responsibilities / person closely associated Name Lisa Miele Reason for the notification Position/status PCA of Gino Miele R&D Director Initial notification Initial notification /Amendment Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor Name genedrive plc LEI 213800ZYODIRZ87Y4K14 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted Description of the Ordinary shares of 1.5 pence each Financial instrument, type of instrument Identification code GB00B1VKB244 Nature of the Purchase transaction Price(s) and volume(s) Price(s) Volume(s) 8.875p 8,636 Aggregated information · Aggregated volume N/A · e. f. Price Date of the transaction Place of the transaction 2020-02-05 London Stock Exchange, AIM For further details please contact: genedrive plc +44 (0)161 989 0245 David Budd: CEO / Matthew Fowler: CFO Peel Hunt LLP (Nominated Adviser and Joint Broker) James Steel / Oliver Jackson +44 (0)20 7418 8900 Stanford Capital Partners Limited (Joint Broker) Patrick Claridge / John Howes +44 (0)20 3815 8880 Walbrook PR Ltd (Media Relations & Investor Relations) Paul McManus / Anna Dunphy +44 (0)20 7933 8780 or genedrive@walbrookpr.com +44 (0)7980 541 893 / +44 (0)7876 741 001 This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. END DSHEAXASEDDEEFA